Add ANI As A Trusted Source For Reliable Information
Search For "casgevy"
Updated : 2 years, 8 months ago IST
The US Food and Drug Administration approved two gene therapies for the treatment of sickle cell disease (SCD) in patients aged 12 years and above.
After rigorous testing on safety, quality and effectiveness Britain's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a world-first gene therapy, that will work to cure sickle-cell disease as well as B-thalassemia.